Steven A Rubin
Steven A Rubin
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Georgios Amexis
Georgios Amexis
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Mikhail Pletnikov
Mikhail Pletnikov
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
2,
Zongqi Li
Zongqi Li
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Jacqueline Vanderzanden
Jacqueline Vanderzanden
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Jeremy Mauldin
Jeremy Mauldin
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Christian Sauder
Christian Sauder
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Tahir Malik
Tahir Malik
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Konstantin Chumakov
Konstantin Chumakov
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,
Kathryn M Carbone
Kathryn M Carbone
DVP/Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 Departments of Psychiatry and Medicine, Johns Hopkins University, Baltimore, Maryland 212052
1,,2
